 SAN DIEGO, Aug. 02, 2022 GLOBE NEWSWIRE -- Kura Oncology, Inc. Nasdaq: KURA, a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in the Wedbush PacGrow Healthcare Virtual Conference. Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in a panel titled Bullseye - Targeted Oncology In with the New at 10:20 a.m. ET 7:20 a.m. PT on Tuesday, August 9, 2022. 